Reload the page to see effects.
-
-
Categories
Applications:
Art,
Cardiology,
Dentistry,
Dermatology,
Developmental Biology,
Gastroenterology,
Gynecology,
Microscopy,
NDE/NDT,
Neurology,
Oncology,
Ophthalmology,
Other Non-Medical,
Otolaryngology,
Pulmonology,
Urology
Business News:
Acquisition,
Clinical Trials,
Funding,
Other Business News,
Partnership,
Patents
Technology:
Broadband Sources,
Doppler,
Probes,
Tunable Sources
Miscellaneous:
Jobs & Studentships,
Student Theses,
Textbooks
-
-
Quotes
-
“
“Our devices are generally indicated for patients who are not well suited to imaging with traditional, tabletop devices...“Bioptigen’s Envisu ophthalmic imaging devices provide a unique degree of flexibility that benefits clinicians and the patients they care for. It’s exciting to be able to market our C-series devices in the United States and support efforts by health-care providers to deliver appropriate medical interventions, especially for the underserved pediatric patient population.
”
-
Eric L. Buckland in
Bioptigen Receives FDA Clearance to Market Envisu Imaging Systems in the USA
-
“
We are looking forward to providing DDW 2012 attendees with informative and interactive demonstrations of our proprietary NvisionVLE Imaging System...The NvisionVLE Imaging System is designed to provide real-time images that will enable physicians to visually assess diseased tissues deeper than is possible with endoscopy, the current standard of care. We’re continuing to make important progress and this has been an exciting year for us, with 510(k) clearance from the FDA and the initiation of our multi-center clinical trial for the evaluation of Barrett’s esophagus.
”
-
Charles Carignan in
NinePoint Medical to Unveil NvisionVLE Imaging System at DDW 2012
-
“
I think that intraoperative OCT will be incredibly useful in the future...I have high hopes for functional OCT (measuring tissue function directly with OCT instead of using surrogate tests like we’re doing with our ‘apps-driven’ platform)...We want to begin moving health care into the home...It would be tremendously useful if my patients could capture OCTs of their own eyes and send them to me to determine if they need to come in. That could both improve care and reduce costs if we can do it safely and effectively. To do this, OCT systems will need to get smaller, cheaper and better. And they are.
”
-
Alexander C. Walsh in
OCT Moves from Clinic to OR to . . . Home?
-
“
This FDA clearance affirms RTVue’s position as the market leader, now with the fastest scan speed of any FDA cleared device available...We continue to leverage our experience in OCT product development and Fourier-domain technology to serve the needs of physicians and patients.
”
-
Jay Wei in
Optovue Announces FDA 510(k) Clearance of the RTVue XR FD-OCT
-
“
I think it's going to dramatically change things...What we hope is that diagnosis is going to get shifted closer and closer to the point of care...We’re developing techniques to get at molecular changes..So much of medicine and pathology are based on structural changes. If we think of a pathologist looking at a slide, he or she looks at the cells and tissue structures. A radiologist will look at how organs and these anatomical structures are arranged...But with a lot of these techniques, we can get the molecular changes where disease starts. So a pathologist that has molecular information, not just structural, will perhaps catch disease earlier. The same is true for Rohit’s work and Gabi’s work.
”
-
Stephen A. Boppart in
Positive Results: A New Era for Medical Diagnostics - News from UIUC
-
“
It's the same challenge, but instead of imaging through the atmosphere, we're imaging through tissue, and instead of imaging a star, we're imaging a cell.
”
-
Stephen A. Boppart in
Computing the best high-resolution 3-D tissue images - News from Beckman Institute at UIUC
-
“
The effectiveness is striking...Because of the aberrations of the human eye, when you look at the retina without adaptive optics you just see variations of light and dark areas that represent the rods and cones. But when you use adaptive optics, you see the rods and cones as distinct objects...are working to compute the best image possible.
”
-
Stephen A. Boppart in
Computing the best high-resolution 3-D tissue images - News from Beckman Institute at UIUC
-
“
Being able to correct aberrations of the entire volume helps us to get a high-resolution image anywhere in that volume...Now you can see tissue structures that previously were not very clear at all.
”
-
Steven G. Adie in
Computing the best high-resolution 3-D tissue images - News from Beckman Institute at UIUC
-
“
The SPECTRALIS Anterior Segment Module paves the way towards digital gonioscopy...Glaucoma surgeons will further benefit from the enhanced depth imaging (EDI) OCT capabilities of SPECTRALIS when assessing filtering blebs and anterior chamber angles.
”
-
Sanjay G. Asrani in
Heidelberg Engineering Receives FDA Clearance for SPECTRALIS® Anterior Segment Module
-
“
We are extremely excited to begin shipments of the Niris 1300e...The Niris 1300e is the culmination of many years of hard work by our team to bring a quality commercial product to the market. The Niris 1300e, combined with the extensive clinical studies, delivers to our users a very cost effective diagnostic tool that provides critical point of care images and detailed information required to best diagnose and manage a multitude of diseases.
”
-
James M. Fulton in
Imalux® receives CE Mark on its enhanced Niris® 1300e Imaging System and begins worldwide commercial shipments
Recent Comments
Eric Swanson » Help Crowd Power OCT News: Share your journal articles, press releases, job & studentship openings, calendar events, and more with the OCT community.
Your Welcome!
Denise A. Valenti » Help Crowd Power OCT News: Share your journal articles, press releases, job & studentship openings, calendar events, and more with the OCT community.
from: Denise A. Valenti, OD, FAAO deniseavalenti@gmail.com I find this website very beneficial. As a ...
See all recent comments